Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Corcept Therapeutics Inc banner

Corcept Therapeutics Inc
XMUN:HTD

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
XMUN:HTD
Watchlist
Price: 102.5 EUR Market Closed
Market Cap: €10.6B
Write Note Create Alert Ask AI
USD
Metric FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Cash & Cash Equivalents
51.5m 31.1m 41.6m 31.3m 76.2m 77.6m 66.3m 135.6m 127.7m 120.5m
Cash Equivalents
51.5m 31.1m 41.6m 31.3m 76.2m 77.6m 66.3m 135.6m 127.7m 120.5m
Short-Term Investments
— 57.7m 165.1m 244.7m 364.5m 145.9m 365.3m 232.7m 257.5m 256.9m
Total Receivables
9.9m 28.2m 17.6m 19.9m 26.2m 27.6m 31.1m 41.1m 54m 59.8m
Accounts Receivables
9.9m 15.3m 17.6m 19.9m 26.2m 27.6m 31.1m 41.1m 54m 59.8m
Other Receivables
0 12.9m 0 0 0 0 0 0 0 0
Inventory
2.3m 4.6m 4.7m 5.4m 4.9m 5m 6.1m 7.7m 12.4m 12.9m
Other Current Assets
2m 2.7m 7.7m 6m 6.7m 10.3m 30.4m 41.6m 20.1m 35.4m
Total Current Assets
65.7m 124.2m 236.8m 307.4m 478.5m 266.5m 499.3m 458.6m 471.6m 485.5m
PP&E Net
200k 500k 700k 4.5m 4.2m 1.5m 1.8m 315k 8m 6.5m
PP&E Gross
200k 500k 700k 4.5m 4.2m 1.5m 1.8m — — —
Accumulated Depreciation
(500k) (400k) (600k) (1.3m) (1.9m) (2.9m) (3.7m) — — —
Long-Term Investments
— 15.3m 0 39.4m 36.2m 112.3m 4.9m 57.2m 219.8m 160.3m
Other Long-Term Assets
2.9m 80.6m 74.2m 61.1m 52.9m 43.5m 77.5m 105.4m 141.1m 184.4m
Total Assets
68.8m 220.5m 311.7m 412.3m 571.7m 423.8m 583.4m 621.5m 840.6m 836.7m
Accounts Payable
2.3m 8.6m 8.3m 7.5m 10.6m 6.9m 12m 17.4m 15.4m 40.4m
Accrued Liabilities
10.4m 21m 25.8m 30.8m 36.9m 40.1m 60.4m 85.3m 125.2m 125.6m
Short-Term Debt
0 0 0 0 0 0 0 0 0 0
Current Portion of Long-Term Debt
14.7m 0 — — — — — — — —
Other Current Liabilities
0 — 1.5m 500k — 500k 100k 1.8m 191k —
Total Current Liabilities
27.4m 29.6m 35.6m 38.8m 47.5m 47.5m 72.5m 104.5m 140.8m 166.1m
Long-Term Debt
0 0 0 0 0 0 0 0 0 0
Other Liabilities
— — 200k 2.3m 900k 400k 9.1m 10.3m 20.2m 22.8m
Total Liabilities
27.4m 29.6m 35.8m 41.1m 48.4m 48m 81.6m 114.8m 161m 188.8m
Common Stock
100k 100k 100k 100k 100k 100k 100k 133k 136k 140k
Retained Earnings
(322.3m) (193.1m) (117.7m) (23.6m) 82.5m 195m 296.4m 402.5m 543.7m 643.4m
Additional Paid In Capital
363.5m 384.1m 417.2m 457.1m 516.1m 591.3m 662.3m 738.5m 832.1m 968.6m
Treasury Stock
— — (23.7m) (62.7m) (75.8m) (410.4m) (456.1m) (635.1m) (696.2m) (966.6m)
Other Equity
— (100k) (100k) 300k 400k (200k) (900k) 609k (217k) 2.3m
Total Equity
41.4m 191m 275.9m 371.2m 523.3m 375.8m 501.8m 506.7m 679.6m 647.8m
Total Liabilities & Equity
68.8m 220.5m 311.7m 412.3m 571.7m 423.8m 583.4m 621.5m 840.6m 836.7m
Common Shares Outstanding
112.7m 114.7m 115m 114.5m 116.7m 105.9m 131m 103.4m 105.1m 106m
DHG
Dhg Pharmaceutical Joint-Stock Co

A profitable, cash-generative pharmaceutical model with disciplined capital intensity

Intrinsic Value Access required
IMP
Imexpharm Corp

A scaled pharmaceutical manufacturer pairing steady margins with volatile working-capital cash flow

Intrinsic Value Access required
DMC
Domesco Medical Import Export Joint Stock Corp

Profitable pharmaceutical operations with improving margins and volatile working-capital cash conversion

Intrinsic Value Access required
OPC
OPC Pharmaceutical JSC

Profitable pharmaceutical operations with working-capital-driven cash volatility

Intrinsic Value Access required

Continue HTD Research

Summary
HTD intrinsic value, competitors valuation, and company profile.
DCF Valuation
HTD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HTD stock valuation using valuation multiples.
Wall St Estimates
HTD price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HTD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Corcept Therapeutics Inc listings:
NASDAQ • USD
CORT
 F • EUR
HTD
 SWB • EUR
HTD
 LSE • USD
0I3Q
ALPHA SPREAD
Follow us
Join 359,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.